G6PD is an acutely responsive sensor of cellular and metabolic stress, which is modulated by a myriad of factors, including diet and environment
Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
Starting concentrations should be minimal, around 0.1% to 0.25%, with extended observation periods
Most safety information comes from preclinical animal studies and practitioner experience reports
Inhibition of glutathione disulfide reductase by glutathione